Ken Griffin Anika Therapeutics, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 5,900 shares of ANIK stock, worth $151,866. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,900
Previous 2,700
118.52%
Holding current value
$151,866
Previous $61,000
144.26%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding ANIK
# of Institutions
119Shares Held
11.9MCall Options Held
5.9KPut Options Held
6.3K-
Trigran Investments, Inc.2.07MShares$53.3 Million5.1% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$40.2 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX810KShares$20.8 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA774KShares$19.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY702KShares$18.1 Million0.0% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $376M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...